Appetite Suppression and Weight Loss : By activating GLP-1 receptors in the hypothalamus and brainstem, GLP-1 (S) increases satiety, slows gastric emptying, and reduces caloric intake ( 2, 3 )
Mantn el vial sellado, seco y protegido de luz, humedad y fuentes de calor
These outcomes are not tied to a single formulation or brand, nor are they intended to suggest results for any specific medication
Changes in efficacy parameters from baseline to week 3 and week 6 and changes from week 3 to week 6 were analyzed using a MMRMs with treatment, baseline BMI stratum, time point (of measurement) and treatment-by-time-point interaction as fixed effects, baseline value as a covariate and participant as a random effect
In the head-to-head SURMOUNT-5 trial (NEJM 2025), tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide at 72 weeks
The twice-weekly dosing schedule integrates easily with other peptide administrations